Detection of Patent Foramen Ovale. Transesophageal Echocardiography and Transcranial Doppler Sonography With Ultrasound Contrast Media are "Supplementary, Not Competing, Diagnostic Methods"
Med Klin 94:367-370, Heckmann,J.G.,et al, 1999

Cerebral Venous Thrombosis
The Neurologist 5:326-349, Biousse,V.&Bousser,M., 1999

Serum Glucose Level and Diabetes Predict Tissue Plasminogen Activator-Related Intracerebral Hemorrhage in Acute Ischemic Stroke
Stroke 30:34-39, Demchuk,A.M.,et al, 1999

Evaluation of Early Computed Tomographic Findings in Acute Ischemic Stroke
Stroke 30:389-392, Marks,M.P.,et al, 1999

"Telestroke",The Application of Telemedicine for Stroke
Stroke 30:464-469, Levine,S.R.&Gorman,M., 1999

Intra-Arterial rtPA Treatment of Stroke Assessed by Diffusion- and Perfusion-Weighted MRI
Stroke 30:678-680, Lansberg,M.G.,et al, 1999

CT Angiography and Doppler Sonography for Emergency Assessment in Acute Basilar Artery Ischemia
Stroke 30:606-612, Brandt,T.,et al, 1999

Diagnosis and Treatment of Ischemic Stroke
Am J Med 106:211-221, Alberts,M.J., 1999

Acute Vertebrobasilar Occlusion:Treatment with High-Dose Intraarterial Urokinase
AJR 172:709-712, Hoffman,A.I.,et al, 1999

Rapid Thrombectomy of Superior Sagittal Sinus and Transverse Sinus Thrombosis with a Rheolytic Catheter Device
AJNR 20:414-417, Opatowsky,M.J.,et al, 1999

Application of a Rheolytic Thrombectomy Device in the Treatment of Dural Sinus Thrombosis:A New Technique
AJNR 20:568-570, Dowd,C.F.,et al, 1999

Evidence of Anaphylaxy after Alteplase Infusion
Stroke 30:1142-1143, Rudolf,J.,et al, 1999

Predicting Deterioration in Patients with Lobar Haemorrhages
JNNP 66:600-605, Flemming,K.D.,et al, 1999

Superselective Intraarterial Fibrinolysis in Central Retinal Artery Occlusion
AJNR 20:565-567, Padolecchia,R.,et al, 1999

Association of Hyperdense Middle Cerebral Artery Sign with Clinical Outcome in Patients Treated with Tissue Plasminogen Activator
Stroke 30:769-772, Manelfe,C.,et al, 1999

Evaluation of Early Reperfusion and IV tPA Therapy Using Diffuion- and Perfusion-Weighted MRI
Neurol 52:1792-1798,1733, Marks,M.P.,et al, 1999

Effects of Tissue Plasminogen Activator for Acute Ischemic Stroke at One Year
NEJM 340:1781-1787, Kwiatkowski,T.G.,et al, 1999

Applications of Diffusion-Perfusion Magnetic Resonance Imaging in Acute Ischemic Stroke
Neurol 52:1750-1756,1733, Fisher,M.&Albers,G.W., 1999

Initial Clinical Experience with IV Tissue Plasminogen Activator for Acute Ischemic Stroke:A Multicenter Survey
Neurol 53:424-427, Tanne,D.,et al, 1999

Consent Issues in the Management of Cerebrovascular Diseases, A Position Paper of the American Academy of Neurology Ethics and Humanities Subcommittee
Neurol 53:9-11, , 1999

Presenting Features and Value of Diagnostic Procedures in Leptomeningeal Metastases
Neurol 53:382-385, van Oostenbrugge,R.J.&Twijnstra,A., 1999

Prethrombotic Disorders in Children with Arterial Ischemic Stroke and Sinovenous Thrombosis
Arch Neurol 56:967-971, Bonduel,M.,et al, 1999

Intraarterial Thrombolysis for Treatment of Acute Stroke:Experience in 26 Patients with Long-Term Follow-Up
AJNR 20:1291-1299, 1194, Jahan,R.,et al, 1999

Is the Routine Use of Intravenous Immunoglobulin Treatment in Neurologic Disorders Justified?
Arch Neurol 56:1028-1032, Karussis,D.&Abramsky,O., 1999

Agreement and Variability in the Interpretation of Early CT Changes in Stroke Patients Qualifying for Intravenous rtPA Therapy
Stroke 30:1528-1533, Grotta,J.C.,et al, 1999

Removal of a Thrombus from the Sigmoid and Transverse Sinuses with a Rheolytic Thrombectomy Catheter
AJNR 20:1467-1469, Scarrow,A.M.,et al, 1999

Significant Reductions in Length of Stay After Carotid Endarterectomy Can Be Safely Accomplished Without Modifying Either Anesthetic Technique or Postoperative ICU Monitoring
Stroke 30:2341-2346, Angevine,P.D.,et al, 1999

Treatment and Secondary Prevention of Stroke:Evidence, Costs, and Effects on Individuals and Populations
Lancet 354:1457-1463, Hankey,G.J.&Warlow,C.P., 1999

Intra-Arterial Cerebral Thrombolysis for Acutre Ischemic Stroke in a Community Hospital
AJNR 20:1682-1687,1580, Edwards,M.T.,et al, 1999

Predictors of Clinical Improvement,Angiographic Recanalization, and Intracranial Hemorrhage After Intra-Arterial Thrombolysis for Acute Ischemic Stroke
Stroke 30:2094-2100, Suarez,J.I.,et al, 1999

Expanding the Window for Thrombolytic Therapy in Acute Stroke, The Potential Role of Acute MRI for Patient Selection
Stroke 30:2230-2237, Albers,G.W., 1999

MRI Features of Intracerebral Hemorrhage Within 2 Hours from Symptom Onset
Stroke 30:2263-2267, Linfante,I.,et al, 1999

The Intensive Care Management of Acute Ischemic Stroke
The Neurologist 5:313-325, Deibert,E.&Diringer,M.N., 1999

Intra-Arterial Prourokinase for Acute Ischemic Stroke, The PROACT II Study:A Randomized Controlled Trial
JAMA 282:2003-2011, Furlan,A.,et al, 1999

Combined Intravenous and Intra-Arterial r-TPA Versus Intra-Arterial Therapy of Acute Ischemic Stroke, Emergency Management of Stroke (EMS) Bridging Trial
Stroke 30:2598-2605, Lewandowski,C.A.,et al, 1999

Recombinant Tissue-Type Plasminogen Activator (Alteplase) for Ischemic Stroke 3 to 5 Hours After Symptom Onset, The ATLANTIS Study:A Randomized Controlled Trial
JAMA 282:2019-2026, Clark,W.M.,et al, 1999

Postoperative Outcome of 37 Patients with Lobar Intracerebral Hemorrhage Related to Cerebral Amyloid Angiopathy
Stroke 30:29-33, Izumihara,A.,et al, 1999

Cerebral Venous Thrombosis,Combined Intrathrombus rtPA and Intravenous Heparin
Stroke 30:489-494,481, Frey,J.L.,et al, 1999

Cerebral Venous Thrombosis,Nothing,Heparin,or Local Thrombolysis?
Stroke 30:481-483, Bousser,M-G, 1999

Surgical Treatment for Intracerebral Hemorrhage (STICH),A Single-Center,Randomized Clinical Trial
Neurol 51:1359-1363, Morgenstern,L.B.,et al, 1998

Risk for Intracranial Hemorrhage after Tissue Plasminogen Activator Treatment for Acute Myocardial Infarction
Ann Int Med 129:597-604, Gurwitz,J.H.,et al, 1998

Thrombolytic Therapy in Acute Stroke
Arch Neurol 55:155-157, Horowitz,S.H., 1998

Risk of Cerebral Sinus Thrombosis in Oral Contraceptive Users Who Are Carriers of Hered Prothrombotic Cond
BMJ 316:589-592, deBruijn,S.F.T.M.,et al, 1998

Cerebrovasc Dis Risk Factors:Neuroradiol Findings in Pts with Activated Protein C Resistance
Radiology 207:85-89, Provenzale,J.M.,et al, 1998

Thrombolysis-Related Intracranial Hemorrhage, Analysis of 224 Cases from GUSTO-1 Trial with Clin Correl
Stroke 29:563-569, Gebel,J.M.,et al, 1998

PROACT:Recombinant Pro-Urokinase by Direct Arterial Delivery in Acute MCA Stroke
Stroke 29:4-11, delZoppo,G.J.,et al, 1998

tPA-Associated Reperfusion After Acute Stroke Demonstrated by SPECT
Stroke 29:429-432, Grotta,G.J.&Alexandrov,A.V., 1998

I. V. t-PA for Acute Ischemic Stroke, Feasibility, Safety & Efficacy in the First Year of Clinical Practice
Stroke 29:18-22, Chiu,D.,et al, 1998

The Need to Quantify Right-to-Left Shunt in Acute Ischemic Stroke, A Case-Control Study
Stroke 29:1322-1328, Serena,J.,et al, 1998

Prevent of a 1st Stroke by Transfusions in Children/Sickle Cell Anemia & Abnorm Results on Transcr Doppler Ultrasonog
NEJM 339:5-11, Adams,R.J.,et al, 1998